We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.225 | 5.11% | 4.625 | 4.50 | 4.75 | 4.625 | 4.625 | 4.63 | 467,812 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.03 | 5.32M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/4/2024 09:39 | Things go in cycles. | hazl | |
05/4/2024 09:38 | I rarely repeat their names but I think you'll find it is impossible to stop. | hazl | |
05/4/2024 09:26 | Cross posting against BB forum rules, report the accounts to get them shut down otherwise gets out of hand and less people visit these sites. Don't respond as you'll give them oxygen! | indomie1 | |
05/4/2024 09:16 | But you came here to promote it. You knew even then that GDR is superior. | hazl | |
05/4/2024 09:11 | Rua told you folks yesterday | lookinggood | |
05/4/2024 09:07 | https://www.londonst | blackhorse23 | |
05/4/2024 09:05 | Imperalist you are inevitably always wrong. A broken clock is more accurate than you. | havinthelasttoast | |
05/4/2024 09:04 | For me, ethically, the product to save using the wrong antibiotics, for little babies is equally important and of course personalised medicine, is the new goal now. Genedrive might be ahead of the pack, but it will generally be used by countries everywhere, in one form or another. IMO | hazl | |
05/4/2024 09:01 | This is such a big market TImp. If one were to look at it purely commercially, strokes are a problem worldwide. This is a huge market. | hazl | |
05/4/2024 08:54 | "genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that the UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance that the Genedrive® CYP2C19-ID test should be used as the point-of-care ("POC") test of choice before clopidogrel administration in the management of Ischemic Stroke ("IS") and Transient Ischaemic Attack ("TIA") patients." Imagine the consequences if the guidance wasn't followed, and a negative outcome was forthcoming..... Am I wrong? | the imperialist | |
05/4/2024 08:51 | Investor presentation in an hour. Hope folk have asked some decent questions! No time to answer them all on the day, so will have time wait until next week to get a written response to some. Expecting a rerate soon with significant sales news due to land within the next 12 months. | indomie1 | |
05/4/2024 08:51 | This is the longer term view: Sales and no-additional-fundin Just my view. Happy to hold. | the imperialist | |
05/4/2024 08:46 | great opening blue start today for GDR and SAAS. Would be a happy friday to see them in the top 10 gainers today as well | citys2874 | |
05/4/2024 08:39 | Lack of sales and dilution-risk are the two factors which have inhibited a sustained share price rise in recent times. The dilution risk is still there, we're close to the wire, but sales must be just around the corner given the last RNS. Potential buyers are almost compelled to make a purchase. Worst case scenario: dilution at a much improved level (less dilution) Best case: Sales land just in time. Happy to hold long term. Just my view. | the imperialist | |
05/4/2024 08:09 | Announcements and solid news and the company ought to thrive at last. IMO | hazl | |
05/4/2024 00:07 | GDR had a great day today i think this and SAAS, both look like multi-baggers to me in the making and very cheap | citys2874 | |
04/4/2024 23:57 | The rise will continue. Just look at the share chart. History repeats itself, and it is always around this time when it shoots up. | kingston78 | |
04/4/2024 16:49 | Thanks for your concern. Still here. Just keeping a low profile. | the imperialist | |
04/4/2024 16:44 | Pleased to still see you here The Imp. I didn't see you yesterday and was concerned you'd missed out on the rise. | hazl | |
04/4/2024 16:35 | Termite's arguments just get weaker lol Next week it will be "ok so you've got to 50p, but it was 200p during lockdown" lol | the imperialist | |
04/4/2024 16:33 | Again health companies take a long time bringing their product to market because of the immense regulations that have to be adhered to. For a simple test, it seems bizarre but that is the way it is. Amazingly, it is easier to invent a new food than a medicine. But if they do succeed....especiall Nothing's certain yet...but that's why there is the excitement. IMO | hazl | |
04/4/2024 16:29 | Oh! bless back he comes! For anyone new ....this Termite or whatever he is called could have got out with his short three days ago! He has missed his profit lost the lot ...now he wants you to lose yours! | hazl | |
04/4/2024 16:21 | I have no objection to offloading a few short term traders at this point. They'll be replaced with the likes of Phil and NY Boy who have bashed their way in. | the imperialist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions